resveratrol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases flow-mediated dilation
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“FMD was higher (P < 0.05) before exercise and at all post-exercise time points in the resveratrol and estradiol conditions compared to placebo.”
Quoted verbatim from Effects of resveratrol or estradiol on postexercise endothelial function in estrogen-deficient postmenopausal women.. - Study
- crossover
- Duration
- 1 day
- Dose
- single 250 mg resveratrol tablet versus placebo, randomized double-blind crossover
- Population
- Healthy estrogen-deficient postmenopausal women; single acute dose, FMD measured before and 30, 60 and 120 min after a 40-min treadmill bout; the estradiol patch condition was a separate crossover arm
Effects of resveratrol or estradiol on postexercise endothelial function in estrogen-deficient postmenopausal women.2020PMID:32134713Permalink
Keep reading
- Everything the graph holds on resveratrol
- Every compound studied against Flow-mediated dilation
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5RXZZ0Q0R4848M7K7TFXQV7